Cardiology
From the Journals
NSAIDs a significant mediator of cardiovascular risk in osteoarthritis
NSAID use could be responsible for a significant proportion of the increased risk of cardiovascular disease associated with osteoarthritis.
From the Journals
Older patients who stop statins may be increasing their cardiovascular risk
Discontinuation of statins was associated with an increased risk of hospital admission for a cardiovascular event.
From the Journals
AI technology meets AFib detection
An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation.
Commentary
ERRATUM
The author list for the June 2019 PURL (“A better approach to the diagnosis of PE.” J Fam Pract. 2019;68:286,287,295)
Clinical Inquiries
Do A-fib patients continue to benefit from vitamin K antagonists with advancing age?
EVIDENCE-BASED ANSWER: Yes, patients with atrial fibrilla- tion who are between the ages of 50 and 90 years continue to benefit from vitamin K...
Conference Coverage
Hypothyroidism may have more impact on cardiac health than hyperthyroidism
Evaluate thyroid function in patients with a fast resting heart fate, new-onset AFib, idiopathic heart failure, bradycardia, resistant...
Conference Coverage
Most patients with new hypertension under revised BP guidelines won’t need pharmacotherapy
ORLANDO – In terms of nonpharmacologic therapies for these patients, the largest benefit is in getting them to lose weight.
Latest News
Acupuncture cuts attacks in chronic angina
Chronic stable angina patients showed significant improvement with acupuncture over patients given sham or no acupuncture.
Opinion
Entresto, inpatient therapy, and surrogate markers
One overriding factor behind the slow uptake of Entresto for heart failure may be the cost of the drug compared to enalapril.
From the Journals
Meeting just 2 of 7 ‘simple’ goals lowers HF risk
From the Journals
Increased cardiovascular risk seen early on with testosterone replacement therapy